Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.39818 | 15 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.37699 | 15 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.3648 | 15 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.32022 | 15 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.35222 | 16 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.43877 | 16 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.42596 | 16 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.42753 | 18 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.35855 | 16 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.36513 | 15 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.36083 | 15 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.35143 | 15 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.38691 | 16 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.37832 | 16 |